Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment
- 1 December 2012
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 39 (2) , 263-272
Abstract
No abstract availableKeywords
This publication has 148 references indexed in Scilit:
- Structure–activity relationship study of beta-carboline derivatives as haspin kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2012
- Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn miceJournal of Neuroscience Research, 2012
- Selective serotonin 5-HT2C receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cuesNeuropharmacology, 2011
- Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expressionNeuropharmacology, 2011
- Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)Archives of Biochemistry and Biophysics, 2011
- Blockade of 5-HT2A receptors in the medial prefrontal cortex attenuates reinstatement of cue-elicited cocaine-seeking behavior in ratsPsychopharmacology, 2010
- Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in ratsPsychopharmacology, 2010
- Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's diseaseJournal of Ethnopharmacology, 2010
- Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's diseaseJournal of Ethnopharmacology, 2010
- Biological substrates of reward and aversion: A nucleus accumbens activity hypothesisNeuropharmacology, 2009